We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.75B
AUM Growth
+$9.65M
Cap. Flow
+$34.6M
Cap. Flow %
1.26%
Top 10 Hldgs %
19.17%
Holding
309
New
22
Increased
110
Reduced
75
Closed
74

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$25.8M
2
FATE icon
Fate Therapeutics
FATE
+$13.9M
3
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$12.3M
4
STER
Sterling Check Corp. Common Stock
STER
+$10.8M
5
SKYT icon
SkyWater Technology
SKYT
+$9.26M

Top Sells

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$19.8M
2
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$18.5M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$17.9M
4
EVER icon
EverQuote
EVER
+$13M
5
ECHO
Echo Global Logistics, Inc.
ECHO
+$12.4M

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Healthcare 20.11%
3 Consumer Discretionary 16.66%
4 Industrials 15.03%
5 Financials 13.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWIM icon
101
Latham Group
SWIM
$692M
$8.89M 0.32%
542,279
+9,120
+2% +$213K
TLYS icon
102
Tilly's
TLYS
$121M
$8.68M 0.32%
619,870
-553
-0.1% -$8.4K
OCUL icon
103
Ocular Therapeutix
OCUL
$1.96B
$8.5M 0.31%
849,600
-373,900
-31% -$4.2M
TMDX icon
104
Transmedics
TMDX
$2.56B
$8.38M 0.3%
253,378
-47,086
-16% -$1.44M
TPTX
105
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$7.71M 0.28%
115,983
-268
-0.2% -$19.1K
ZVIA icon
106
Zevia
ZVIA
$122M
$7.42M 0.27%
+644,730
New +$8.56M
TMCI icon
107
Treace Medical Concepts
TMCI
$279M
$7.31M 0.27%
271,877
+1,470
+0.5% +$40.4K
AAPL icon
108
Apple
AAPL
$4.9T
$7.28M 0.26%
51,468
+3
+0% +$442
WHD icon
109
Cactus
WHD
$3.78B
$7.12M 0.26%
+188,783
New +$6.81M
MSFT icon
110
Microsoft
MSFT
$2.93T
$6.54M 0.24%
23,216
+1
+0% +$291
CCNE icon
111
CNB Financial Corp
CCNE
$1.02B
$6.41M 0.23%
263,177
– –
CVRX icon
112
CVRx
CVRX
$130M
$6.22M 0.23%
376,311
+136,591
+57% +$2.62M
AVIR icon
113
Atea Pharmaceuticals
AVIR
$390M
$6.1M 0.22%
+173,950
New +$4.82M
KALV
114
DELISTED
KalVista Pharmaceuticals
KALV
$5.31M 0.19%
304,113
-70,520
-19% -$1.43M
MASS icon
115
908 Devices
MASS
$302M
$4.32M 0.16%
+132,769
New +$4.51M
AMZN icon
116
Amazon
AMZN
$2.66T
$4.17M 0.15%
25,420
– –
GOOGL icon
117
Alphabet (Google) Class A
GOOGL
$4.23T
$3.91M 0.14%
29,280
+3,140
+12% +$427K
THRN
118
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$3.82M 0.14%
+441,890
New +$3.61M
HZNP
119
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.49M 0.13%
31,845
-839
-3% -$87.1K
NVDA icon
120
NVIDIA
NVDA
$4.91T
$3.44M 0.12%
165,880
– –
GNRC icon
121
Generac Holdings
GNRC
$12.7B
$3.13M 0.11%
7,668
-24
-0.3% -$10.3K
HUBS icon
122
HubSpot
HUBS
$11.5B
$3.13M 0.11%
4,636
-24
-0.5% -$15.5K
LNG icon
123
Cheniere Energy
LNG
$55B
$2.79M 0.1%
28,617
-4,073
-12% -$356K
DOCU
124
DocuSign
DOCU
$10.1B
$2.6M 0.09%
10,100
-331
-3% -$95.4K
META icon
125
Meta Platforms (Facebook)
META
$1.64T
$2.6M 0.09%
7,654
-1,108
-13% -$399K
3 4
5
6 7

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Emerald Advisers held 309 positions worth $2.75B, up 0.35% from $2.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers's Q3 2021 filing shows 22 new, 110 increased, 75 reduced and 74 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M. The largest sale was The AZEK Co, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M.
  • Emerald Advisers added most to SkyWater Technology in Q3 2021, an estimated $9.26M increase.
  • Emerald Advisers's biggest Q3 2021 reduction was EverQuote, cutting an estimated $13M.
  • Emerald Advisers fully exited The AZEK Co in Q3 2021, selling an estimated $19.8M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.75B portfolio in Q3 2021.
  • Emerald Advisers opened 22 new positions and closed 74 in Q3 2021.
  • Emerald Advisers's portfolio value rose 0.35% quarter-over-quarter to $2.75B.

Based on Emerald Advisers's 13F filing for Q3 2021, filed 28 Oct 2021.